These short videos explain the latest results from the following clinical trials, and are published on Oncology Tube:

CARMENA – nephrectomy plus sunitinib versus sunitinib alone for advanced renal cell carcinoma (RCC)

KEYNOTE 427 – first-line pembrolizumab in metastatic RCC

CheckMate-214 – first-line ipilimumab plus nivolumab combination versus sunitinib in metastatic RCC

RCC treatment after failure of immuno-oncology